Fresenius Medical Care AG (FMS) Form 6-K — May 5, 2026
Fresenius Medical Care reported first quarter 2026 revenue of EUR 4,612 million, a decrease of 6% year-over-year but an increase of 3% at constant currency, with organic growth of 4% across all operating segments. While reported operating income fell 14% to EUR 286 million due to EUR 166 million in one-time transformation costs, adjusted operating income grew 10% at constant currency to EUR 467 million, driving margin expansion to 10.1%. The company confirmed its full-year 2026 outlook for broadly flat revenue growth and operating income to remain on a consistent level.
Key figures
- Eps
- 0.43
- Revenue
- 4612000000
- Net Income
- 118000000
- Total Debt
- 9790000000
- Revenue Yoy
- -5.5%
- Cash Position
- 1239000000
- Adjusted EPS
- 0.91
- Free Cash Flow
- 40000000
- Special Items
- 181000000
- Operating Income
- 286000000
- Net Leverage Ratio
- 2.6x
- Organic Revenue Growth
- 4%
- Share Buyback Spend YTD
- 941000000
- Shares Repurchased YTD
- 23300000
- Adjusted Operating Income
- 467000000
- Adjusted Operating Income Margin
- 10.1%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.